A Study of GS-2426 in People With Solid Tumor Cancer

Full Title

A Phase 1, Multicenter, Open-Label Clinical Study to Evaluate the Safety and Tolerability of GS-2426 in Participants with Advanced MTAP-Deleted Solid Tumors

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Kathryn Arbour’s office at 646-888-4226.

Protocol
26-264
Phase
Phase I (phase 1)
Investigator
Kathryn C. Arbour
Co-Investigators
Mrinal M. Gounder
Diseases
Solid Tumors
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT07601243
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description